Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN previous answer version answering member constituency answering member constituency answering member printed answering member printed answering member label answering member label question first answered question first ministerially corrected answering member label
tabling member	label

Search

1537499

registered interest
date	31/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tixagevimab/cilgavimab: USA
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether her Department has had discussions with the Centre for Disease Control in the US on their use of Evusheld as a pre-exposure prophylaxis to prevent Covid-19 in people who are moderately to severely immunocompromised.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	74934
answer	answer is ministerial correction date of answer 08/11/2022 answer text <p>The Antivirals and Therapeutics Taskforce has regular engagement with international partners to share learning on the use, deployment and evaluation of therapeutics and antivirals, including Evusheld. The Taskforce recently met with counterparts from the United States of America and discussed the recent change to the Food and Drug Administration’s treatment guidelines, which recommends physicians advise individuals to have appropriate alternate treatment plans in place, should emerging COVID-19 variants be resistant to Evusheld.</p><p>We continue monitoring whether and how other countries are using pre-exposure prophylactic treatments in people who are moderately to severely immunocompromised.</p> answering member constituency Colchester answering member printed Will Quince question first answered 08/11/2022 15:42:46 answering member 4423 label Biography information for Will Quince
tabling member	4769 label Biography information for Daisy Cooper

1537500

registered interest
date	31/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made any preparations to introduce antibody testing before Christmas 2022 for immunocompromised and immunosuppressed patients who may not mount a full response to Covid vaccines.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	74935
answer	answer is ministerial correction date of answer 04/11/2022 answer text <p>The Antivirals and Therapeutics Taskforce is exploring options for a pilot study to test antibody levels in immunosuppressed patients to provide clinical evidence of a potential protective vaccine response. This could inform a wider testing programme identifying those who have mounted a protective antibody response following vaccination and provide more informed advice.</p><p>No specific cost estimate has yet been made. However, officials are in discussions with experts in this area and further information will be available in due course.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 74936 question first answered 04/11/2022 13:25:49 answering member 4423 label Biography information for Will Quince
tabling member	4769 label Biography information for Daisy Cooper

1535553

registered interest
date	24/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Palivizumab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 September to Question 47662, whether a specific date has been confirmed for NHS England’s Palivizumab National Expert Group to report its recommendations to the JCVI.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	69808
answer	answer is ministerial correction date of answer 02/11/2022 answer text <p>The Palivizumab National Expert Group has now reported the outcome of its discussion and recommendations to the Joint Committee on Vaccination Immunisation, which will be discussed in a forthcoming meeting. A specific date has for this meeting has not yet been confirmed.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 02/11/2022 11:49:11 answering member 4679 label Biography information for Neil O'Brien
tabling member	4769 label Biography information for Daisy Cooper

1524046

registered interest
date	19/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tixagevimab/cilgavimab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has (a) sought and (b) received advice from immunologists on the effectiveness of Evusheld.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	67224
answer	answer is ministerial correction date of answer 01/11/2022 answer text <p>The Government’s decision not to procure Evusheld at this time was based on independent clinical advice by the multi-agency RAPID C-19 <del class="ministerial">and a United Kingdom national expert policy working group. RAPID C-19</del> <ins class="ministerial">. </ins><ins class="ministerial">DHSC also </ins>sought advice from <del class="ministerial">the</del> <ins class="ministerial">a United Kingdom national </ins>expert <ins class="ministerial">policy </ins>working group, which includes a range of expertise including immunology, virology and relevant specialisms such as oncology. The membership of these groups also included experts in interpreting and analysing complex data, including clinicians and pharmacists, evidence assessors, and researchers.</p> answering member constituency Colchester answering member printed Will Quince previous answer version 26776 answering member constituency Newark answering member printed Robert Jenrick answering member 4320 label Biography information for Robert Jenrick 29371 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince question first answered 01/11/2022 12:26:19 question first ministerially corrected 21/02/2023 14:40:12 answering member 4423 label Biography information for Will Quince
tabling member	4769 label Biography information for Daisy Cooper

1523425

registered interest
date	18/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tixagevimab/cilgavimab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the contribution by the Minister of State at the Department of Health and Social Care on 12 October to the Westminster Hall debate on the Procurement of Evusheld, Official Report, column 107WH, on what date she plans to announce the accelerated timetable for the NICE assessment of Evusheld.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	66027
answer	answer is ministerial correction date of answer 25/10/2022 answer text <p>The National Institute for Health and Care Excellence (NICE) is conducting a Health Technology Evaluation of Evusheld. This is the routine process for new medicines to be evaluated for clinical and cost effectiveness, which will provide recommendations through NICE’s guidance on the use of Evusheld in the National Health Service. The NICE appraisal is in development and publication is expected in spring 2023.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 25/10/2022 14:57:30 answering member 4320 label Biography information for Robert Jenrick previous answer version 25963 answering member constituency Newark answering member printed Robert Jenrick answering member 4320 label Biography information for Robert Jenrick
tabling member	4769 label Biography information for Daisy Cooper

1523426

registered interest
date	18/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tixagevimab/cilgavimab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Minister of Health's oral contribution on 13 October 2022, Official Report, column 107WH, by what date he expects to complete the review of the (a) Francis Crick Institute study and (b) Lancet Journal article; and if he set out details of how that review will be conducted.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	66028
answer	answer is ministerial correction date of answer 25/10/2022 answer text <p>The review will be conducted in due course by the RAPID C-19 members, including the National Institute for Health and Care Research, the National Institute for Health and Care Excellence, the Medicines and Healthcare products Regulatory Agency, NHS England and representatives from the devolved administrations.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 25/10/2022 16:35:41 answering member 4320 label Biography information for Robert Jenrick previous answer version 25965 answering member constituency Newark answering member printed Robert Jenrick answering member 4320 label Biography information for Robert Jenrick
tabling member	4769 label Biography information for Daisy Cooper

1523670

registered interest
date	18/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the remit of the RAPID C19 taskforce includes fast tracking the roll-out of approved covid-19 treatments.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	66029
answer	answer is ministerial correction date of answer 02/11/2022 answer text <p>RAPID C-19 is a multi-agency initiative including NIHR, NICE, MHRA, NHSE&amp;I and representatives from the devolved governments. When treatments are proven to be safe and effective, the RAPID C-19 group works to get treatments for COVID-19 to NHS patients quickly and safely, by providing a streamlined process from horizon scanning, to regulatory approval, to patients. This initiative has already enabled rapid patient access to therapeutics including dexamethasone, remdesivir, tocilizumab and sarilumab and baricitinib and novel antibody treatments such as casirivimab and imdevimab and sotrovimab, and the two oral antivirals molnupiravir and nirmatralvir+ritonavir (Paxlovid).</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 02/11/2022 12:18:28 answering member 4679 label Biography information for Neil O'Brien previous answer version 25966 answering member constituency Newark answering member printed Robert Jenrick answering member 4320 label Biography information for Robert Jenrick
tabling member	4769 label Biography information for Daisy Cooper

1523697

registered interest
date	18/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Members: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when she plans to respond to the letters of (a) 13 May, (b) 7 September, (c) 29 September and (d) 17 October from the hon. Member for St Albans.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	66030
answer	answer is ministerial correction date of answer 28/10/2022 answer text <p>We replied to the hon. Member on 16 August 2022.</p> answering member constituency Colchester answering member printed Will Quince question first answered 28/10/2022 11:58:18 answering member 4423 label Biography information for Will Quince
tabling member	4769 label Biography information for Daisy Cooper

1522608

registered interest
date	14/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Social Services: Employment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to fill adult social care vacancies in England; and what steps she is taking to improve (a) pay and (b) contractual terms and conditions in that sector.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	63336
answer	answer is ministerial correction date of answer 24/10/2022 answer text <p>Local authorities are responsible for ensuring there is sufficient workforce capacity to meet the care needs of the local population.</p><p>The majority of care workers are employed by private sector providers which set their pay and terms and conditions, independently of central Government. Local authorities work with care providers to determine fee rates, which should take account of wage costs, based on local market conditions.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 24/10/2022 16:32:10 answering member 4679 label Biography information for Neil O'Brien
tabling member	4769 label Biography information for Daisy Cooper

1522609

registered interest
date	14/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Social Services: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will take steps to ensure there are no cuts to the level of spending on adult social cares services.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	63337
answer	answer is ministerial correction date of answer 24/10/2022 answer text <p>The Local Government Finance Settlement for 2022/23 makes available an additional £3.7 billion to councils, including £1 billion for social care. The provisional Local Government Finance Settlement for 2023/24 will be published as soon as possible.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 24/10/2022 16:29:18 answering member 4679 label Biography information for Neil O'Brien
tabling member	4769 label Biography information for Daisy Cooper